239 related articles for article (PubMed ID: 17437951)
1. [The pathophysiology, clinical signs and therapy of urate nephropathy].
Méhes L; Udvardy M; Szász R; Rejto L
Orv Hetil; 2007 Apr; 148(16):745-8. PubMed ID: 17437951
[TBL] [Abstract][Full Text] [Related]
2. [Acute renal failure in patients with tumor lysis syndrome].
Nabeshima K; Saito S; Suzuki Y
Nihon Rinsho; 2004 May; 62 Suppl 5():486-90. PubMed ID: 15197969
[No Abstract] [Full Text] [Related]
3. Tumor lysis syndrome: pathogenesis and management.
Jones DP; Mahmoud H; Chesney RW
Pediatr Nephrol; 1995 Apr; 9(2):206-12. PubMed ID: 7794722
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome.
Davidson MB; Thakkar S; Hix JK; Bhandarkar ND; Wong A; Schreiber MJ
Am J Med; 2004 Apr; 116(8):546-54. PubMed ID: 15063817
[TBL] [Abstract][Full Text] [Related]
5. Tumor lysis syndrome: new challenges and recent advances.
Wilson FP; Berns JS
Adv Chronic Kidney Dis; 2014 Jan; 21(1):18-26. PubMed ID: 24359983
[TBL] [Abstract][Full Text] [Related]
6. The management of tumor lysis syndrome.
Rampello E; Fricia T; Malaguarnera M
Nat Clin Pract Oncol; 2006 Aug; 3(8):438-47. PubMed ID: 16894389
[TBL] [Abstract][Full Text] [Related]
7. A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis.
Goldman SC; Holcenberg JS; Finklestein JZ; Hutchinson R; Kreissman S; Johnson FL; Tou C; Harvey E; Morris E; Cairo MS
Blood; 2001 May; 97(10):2998-3003. PubMed ID: 11342423
[TBL] [Abstract][Full Text] [Related]
8. [Acute renal failure in patients with tumour lysis sindrome].
Poskurica M; Petrović D; Poskurica M
Srp Arh Celok Lek; 2016; 144(3-4):232-9. PubMed ID: 27483573
[TBL] [Abstract][Full Text] [Related]
9. Rasburicase for the treatment of tumor lysis in hematological malignancies.
Malaguarnera G; Giordano M; Malaguarnera M
Expert Rev Hematol; 2012 Feb; 5(1):27-38. PubMed ID: 22272702
[TBL] [Abstract][Full Text] [Related]
10. Management of hyperuricemia with rasburicase review.
de Bont JM; Pieters R
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1431-40. PubMed ID: 15571272
[TBL] [Abstract][Full Text] [Related]
11. Tumor lysis syndrome.
Jeha S
Semin Hematol; 2001 Oct; 38(4 Suppl 10):4-8. PubMed ID: 11694945
[TBL] [Abstract][Full Text] [Related]
12. Recurrent chemotherapy-induced tumor lysis syndrome (TLS) with renal failure in a patient with chronic lymphocytic leukemia - successful treatment and prevention of TLS with low-dose rasburicase.
Hummel M; Buchheidt D; Reiter S; Bergmann J; Adam K; Hehlmann R
Eur J Haematol; 2005 Dec; 75(6):518-21. PubMed ID: 16313266
[TBL] [Abstract][Full Text] [Related]
13. [Hyperuricemia and the kidney].
Ichida K; Hikita M; Hosoya T
Nihon Rinsho; 1996 Dec; 54(12):3277-82. PubMed ID: 8976105
[TBL] [Abstract][Full Text] [Related]
14. [Rasburicase (Fasturtec)].
Vogt B; Gugger M; Frey FJ
Ther Umsch; 2004 Sep; 61(9):579-82. PubMed ID: 15493120
[TBL] [Abstract][Full Text] [Related]
15. Recombinant urate oxidase (rasburicase) for the prevention and treatment of tumor lysis syndrome in patients with hematologic malignancies.
Wang LY; Shih LY; Chang H; Jou ST; Lin KH; Yeh TC; Lin SF; Liang DC
Acta Haematol; 2006; 115(1-2):35-8. PubMed ID: 16424647
[TBL] [Abstract][Full Text] [Related]
16. Rational use of rasburicase for the treatment and management of tumor lysis syndrome.
Shaikh SA; Marini BL; Hough SM; Perissinotti AJ
J Oncol Pharm Pract; 2018 Apr; 24(3):176-184. PubMed ID: 28077046
[TBL] [Abstract][Full Text] [Related]
17. Avoiding dialysis in tumour lysis syndrome: is urate oxidase effective? - a case report and review of literature.
Teo WY; Loh TF; Tan AM
Ann Acad Med Singap; 2007 Aug; 36(8):679-83. PubMed ID: 17767339
[TBL] [Abstract][Full Text] [Related]
18. Onco-nephrology: tumor lysis syndrome.
Wilson FP; Berns JS
Clin J Am Soc Nephrol; 2012 Oct; 7(10):1730-9. PubMed ID: 22879434
[TBL] [Abstract][Full Text] [Related]
19. Tumor Lysis Syndrome.
Barbar T; Jaffer Sathick I
Adv Chronic Kidney Dis; 2021 Sep; 28(5):438-446.e1. PubMed ID: 35190110
[TBL] [Abstract][Full Text] [Related]
20. Rasburicase for Tumor Lysis Syndrome.
Vishwanathan S; Arumugarajah A; Ortega LM; Bousamra A
Am J Ther; 2019; 26(1):e118-e121. PubMed ID: 27563802
[No Abstract] [Full Text] [Related]
[Next] [New Search]
